title: 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).
abstract: The 2015 9th Workshop on Recent Issues in Bioanalysis (9th WRIB) took place in Miami, Florida with participation of 600 professionals from pharmaceutical and biopharmaceutical companies, biotechnology companies, contract research organizations and regulatory agencies worldwide. WRIB was once again a 5 day, week-long event - A Full Immersion Bioanalytical Week - specifically designed to facilitate sharing, reviewing, discussing and agreeing on approaches to address the most current issues of interest in bioanalysis. The topics covered included both small and large molecules, and involved LCMS, hybrid LBA/LCMS and LBA approaches, including the focus on biomarkers and immunogenicity. This 2015 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop, and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2015 edition of this comprehensive White Paper has been divided into three parts. Part 3 discusses the recommendations for large molecule bioanalysis using LBA, biomarkers and immunogenicity. Part 1 (small molecule bioanalysis using LCMS) and Part 2 (hybrid LBA/LCMS and regulatory inputs from major global health authorities) have been published in volume 7, issues 22 and 23 of Bioanalysis, respectively.
authors.affiliation: BiogenIdec, Cambridge, MA, USA.
authors.forename: Lakshmi
authors.initials: L
authors.lastname: Amaravadi
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: An
authors.initials: A
authors.lastname: Song
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Heather
authors.initials: H
authors.lastname: Myler
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Theingi
authors.initials: T
authors.lastname: Thway
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Kirshner
authors.affiliation: Abbvie, Souderton, PA, USA.
authors.forename: Viswanath
authors.initials: V
authors.lastname: Devanarayan
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Yan G
authors.initials: YG
authors.lastname: Ni
authors.affiliation: Angelini Pharma, Pomezia, RM, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Garofolo
authors.affiliation: Roche Pharma Research and EarlyDevelopment, Roche Innovation Center, Basel, Switzerland.
authors.forename: Herbert
authors.initials: H
authors.lastname: Birnboeck
authors.affiliation: Sanofi, Framingham, MA, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Richards
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Shalini
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Linlin
authors.initials: L
authors.lastname: Luo
authors.affiliation: LGC, Cambridge, UK.
authors.forename: Clare
authors.initials: C
authors.lastname: Kingsley
authors.affiliation: Sanofi, Framingham, MA, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Salazar-Fontana
authors.affiliation: Pfizer, Groton, CT, USA.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Fraser
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Boris
authors.initials: B
authors.lastname: Gorovits
authors.affiliation: LGC, Cambridge, UK.
authors.forename: John
authors.initials: J
authors.lastname: Allinson
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Troy
authors.initials: T
authors.lastname: Barger
authors.affiliation: Bristol-Myers Squibb, Philadelphia, PA, USA.
authors.forename: Shannon
authors.initials: S
authors.lastname: Chilewski
authors.affiliation: Novo Nordisk A/S, Maaloev, Denmark.
authors.forename: Marianne Scheel
authors.initials: MS
authors.lastname: Fjording
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Sam
authors.initials: S
authors.lastname: Haidar
authors.affiliation: Celerion, Lincoln, NE, USA.
authors.forename: Rafiqul
authors.initials: R
authors.lastname: Islam
authors.affiliation: Novartis Pharma, Basel, Switzerland.
authors.forename: Birgit
authors.initials: B
authors.lastname: Jaitner
authors.affiliation: Eurofins Bioanalytical Services, St Charles, MO, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kamerud
authors.affiliation: Japan MHLW-NIHS, Tokyo, Japan.
authors.forename: Noriko
authors.initials: N
authors.lastname: Katori
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Corinna
authors.initials: C
authors.lastname: Krinos-Fiorotti
authors.affiliation: Eurofins Bioanalytical Services, Abingdon, Oxfordshire, UK.
authors.forename: David
authors.initials: D
authors.lastname: Lanham
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Ma
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Jim
authors.initials: J
authors.lastname: McNally
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Alyssa
authors.initials: A
authors.lastname: Morimoto
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Mytych
authors.affiliation: UCB Biopharma, Braine L'Alleud, Belgium.
authors.forename: Andre
authors.initials: A
authors.lastname: Nogueira da Costa
authors.affiliation: Roche Pharma Research and EarlyDevelopment, Roche Innovation Center, Penzberg, Germany.
authors.forename: Apollon
authors.initials: A
authors.lastname: Papadimitriou
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Renuka
authors.initials: R
authors.lastname: Pillutla
authors.affiliation: BiogenIdec, Cambridge, MA, USA.
authors.forename: Soma
authors.initials: S
authors.lastname: Ray
authors.affiliation: Bioagilytix Labs, Durham, NC, USA.
authors.forename: Afshin
authors.initials: A
authors.lastname: Safavi
authors.affiliation: CFABS, Laval, QC, Canada.
authors.forename: Natasha
authors.initials: N
authors.lastname: Savoie
authors.affiliation: Roche Pharma Research and EarlyDevelopment, Roche Innovation Center, Penzberg, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Schaefer
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Judy
authors.initials: J
authors.lastname: Shih
authors.affiliation: UCB Biopharma, Braine L'Alleud, Belgium.
authors.forename: John
authors.initials: J
authors.lastname: Smeraglia
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Skelly
authors.affiliation: Merck, Rahway, NJ, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Spond
authors.affiliation: Roche Pharma Research and EarlyDevelopment, Roche Innovation Center, Penzberg, Germany.
authors.forename: Roland F
authors.initials: RF
authors.lastname: Staack
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Stouffer
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Nilufer
authors.initials: N
authors.lastname: Tampal
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY, USA.
authors.forename: Albert
authors.initials: A
authors.lastname: Torri
authors.affiliation: Dutch MEB, Utrecht, The Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: Welink
authors.affiliation: Janssen R&D, Spring House, PA, USA.
authors.forename: Tong-Yuan
authors.initials: TY
authors.lastname: Yang
authors.affiliation: Sanofi, Framingham, MA, USA.
authors.forename: Jad
authors.initials: J
authors.lastname: Zoghbi
mesh_terms: D057134:Antibodies, Neutralizing / Q000276:immunology*; D001681:Biological Assay; D015415:Biomarkers / Q000032:analysis*; D001702:Biopharmaceutics / Q000458:organization & administration*; D001709:Biotechnology / Q000458:organization & administration*; D006801:Humans
chemical_list: D057134:Antibodies, Neutralizing; D015415:Biomarkers